T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Construction Partners
ROAD
$6.9B
| $772K | ﹤0.01% |
24,583
+442
| +2% | +$12.7K |
|
|
ROVR
1927
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $771K | ﹤0.01% |
156,839
+138,970
| +778% | +$636K |
|
1928
Claros Mortgage Trust
CMTG
$262M
| $769K | ﹤0.01% |
67,750
+3,405
| +5% | +$38.3K |
|
1929
Virtu Financial
VIRT
$5.04B
| $768K | ﹤0.01% |
44,931
+311
| +0.7% | +$5.7K |
|
1930
TripAdvisor
TRIP
$1.26B
| $766K | ﹤0.01% |
46,392
+2,526
| +6% | +$42.8K |
|
|
ACH
1931
Accendra Health
ACH
$84.6M
| $762K | ﹤0.01% |
40,009
+1,101
| +3% | +$19.6K |
|
|
NXGN
1932
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $762K | ﹤0.01% |
46,927
-6,289
| -12% | -$104K |
|
1933
Brookfield Renewable
BEPC
$6.5B
| $761K | ﹤0.01% |
24,140
-260
| -1% | -$8.77K |
|
1934
Manitowoc
MTW
$727M
| $759K | ﹤0.01% |
40,275
+6,625
| +20% | +$107K |
|
1935
CoreCivic
CXW
$3.32B
| $755K | ﹤0.01% |
80,167
+1,080
| +1% | +$9.8K |
|
1936
Geron
GERN
$982M
| $755K | ﹤0.01% |
235,133
+79,322
| +51% | +$226K |
|
1937
StoneCo
STNE
$2.49B
| $754K | ﹤0.01% |
59,111
+6,066
| +11% | +$75.7K |
|
|
VSXY
1938
Victoria's Secret
VSXY
$7.39B
| $754K | ﹤0.01% |
43,223
-8,387
| -16% | -$211K |
|
|
HBI
1939
DELISTED
Hanesbrands
HBI
| $753K | ﹤0.01% |
165,705
+25,237
| +18% | +$115K |
|
1940
Cannae Holdings
CNNE
$675M
| $752K | ﹤0.01% |
37,195
+887
| +2% | +$17K |
|
1941
Ligand Pharmaceuticals
LGND
$5.76B
| $752K | ﹤0.01% |
10,418
+835
| +9% | +$62.7K |
|
1942
First Busey Corp
BUSE
$2.58B
| $750K | ﹤0.01% |
37,289
+867
| +2% | +$16.6K |
|
1943
ATN International
ATNI
$478M
| $747K | ﹤0.01% |
20,387
+2,783
| +16% | +$107K |
|
1944
AAR Corp
AIR
$5.96B
| $746K | ﹤0.01% |
12,911
+708
| +6% | +$38.2K |
|
1945
Hovnanian Enterprises
HOV
$793M
| $745K | ﹤0.01% |
7,501
-325
| -4% | -$26.8K |
|
|
AVTA
1946
DELISTED
Avantax, Inc. Common Stock
AVTA
| $743K | ﹤0.01% |
33,176
+1,365
| +4% | +$32.1K |
|
1947
Viking Therapeutics
VKTX
$3.84B
| $739K | ﹤0.01% |
+45,564
| New | +$955K |
|
1948
Standex International
SXI
$4B
| $738K | ﹤0.01% |
5,214
+176
| +3% | +$23.2K |
|
1949
Five Star Bancorp
FSBC
$1.16B
| $737K | ﹤0.01% |
32,879
+345
| +1% | +$7K |
|
1950
Methode Electronics
MEI
$602M
| $737K | ﹤0.01% |
21,973
+471
| +2% | +$19.2K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.